Author:
Chi K.N.,Beardsley E.,Eigl B.J.,Venner P.,Hotte S.J.,Winquist E.,Ko Y.-J.,Sridhar S.S.,Weber D.,Saad F.
Reference17 articles.
1. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
3. Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo;O’Reilly;Prostate,2005
4. Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study;ten Bokkel Huinink;J Clin Oncol,2009
5. Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors;Rubin;J Clin Oncol,2005
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献